As the first month of 2026 comes to an end this week and earnings season accelerates, below is a list of the top 10 consumer ...

Johnson & Johnson remains a buy as business momentum accelerates, with Q4 revenue up 9.1% YoY and strong U.S. sales ...

U.S. Bancorp names CEO Gunjan Kedia as chair after April meeting as Andy Cecere retires—get leadership-change impact and ...

MSCI (MSCI) on Wednesday delivered below-consensus guidance for the full year even as Q4 2025 earnings rose more than ...

Aritzia is rated a buy, driven by robust US-led growth and expanding digital engagement. ATZAF’s US revenue surged 53.8% y/y ...

Shutdown risk is rising again as lawmakers near a deadline. Learn what the practical realities of the government shutting ...

SQM said its merger with the lithium unit of Chile's state-owned Codelco is fully complete after the country's Supreme Court ...

UnitedHealth (UNH) and peers face significant margin risk after the CMS's 2027 Medicare Advantage rate proposal fell short of ...

F.N.B. Corp (FNB) remains well-placed to capitalize on Southeast U.S. growth with a full-service model that can offer ...

In the fourth quarter, Revolve’s stock rose as its revenue met expectations with a 4.4% year-over-year increase. Read more ...

Zeta Global: accelerating AI marketing cloud growth, margin expansion, and rising FCF. Click for more on ZETA stock.

The Allspring Common Stock Fund outperformed the Russell 2500 Index during the period. For the full year, the strategy faced ...